Rare University offers a free 12-lesson course designed specifically for rare disease patients and advocates. The course will explore the following: 1. An introduction to the drug development process and…
FDA Orphan Designation Moves Vybion’s Huntington’s Therapy Closer To Clinical Trial
Read the most recent news on the Vybion's Huntington's Therapy from the Huntington's Disease News.
Roche Phase 3 Clinical Trial for Huntington’s Disease Gene-Silencing Drug to Enroll Volunteers – Early 2019
Dear friends in the fight against Huntington's disease, Pharma giant Roche expects to start enrolling subjects worldwide (including the U.S.) in early 2019 in its historic Phase 3 clinical trial…
Gene Silencing Therapies
Huntington's Disease News reports on a new treatment known as Gene Silencing Therapies. Read more by Victoria Tan here.